Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIND: Melatonin Neuroprotection Dosage Study
ISRCTN01115788Phase 2Completed
- Sponsor
- Imperial College London
- Start
- May 2010
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of melatonin, sponsored by Imperial College London. Primary endpoint: Target serum melatonin concentration. Started May 2010; status: completed.
02
Drugs
melatonin
Beyond the preview
Go deeper on ISRCTN01115788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN01115788.